Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.36 |
| ▸ | CD38 | P28907 | 6/20 | 0.32 |
| ▸ | HCRTR1 | O43613 | 1/20 | 0.31 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32687336 | 0.94 | GPR119 (0.36) | GPR119CD38HCRTR1HCRTR2 | |
| SCHEMBL32687771 | 0.92 | GPR119 (0.38) | GPR119CD38HCRTR1HCRTR2 | |
| SCHEMBL32687522 | 0.90 | GPR119 (0.36) | GPR119CD38HCRTR1HCRTR2 | |
| SCHEMBL32687139 | 0.89 | GPR119 (0.38) | GPR119CD38HCRTR1HCRTR2 | |
| SCHEMBL32687603 | 0.89 | GPR119 (0.36) | GPR119CD38HCRTR1HCRTR2 | |
| SCHEMBL32687018 | 0.89 | IKBKB (0.31) | — | |
| SCHEMBL32687085 | 0.89 | HDAC1 (0.31) | — | |
| SCHEMBL32687122 | 0.88 | GPR119 (0.35) | GPR119CD38HCRTR1HCRTR2 | |
| SCHEMBL32687764 | 0.87 | GPR119 (0.39) | GPR119CD38HCRTR1HCRTR2 | |
| SCHEMBL32687234 | 0.87 | GPR119 (0.38) | GPR119CD38HCRTR1HCRTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260109696-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260078116-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | Interdict Bio, Inc. (US) | 2026-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078116-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | MYC, KRAS, MCL1 | GPR119 3997/4885CD38 2044/4885HCRTR1 4584/4885 |
| US-20260109696-A1 | SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS | KRAS, MYC, NRAS | GPR119 3752/4885CD38 1590/4885HCRTR1 3614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.